Home
About
Publications Trends
Recent Publications
Expert Search
Archive
progestins
What are Progestins?
Progestins are synthetic hormones that mimic the effects of the natural hormone
progesterone
. They are commonly used in various medical treatments, including
hormonal therapy
for cancer, contraception, and hormone replacement therapy (HRT).
Frequently asked queries:
What are Progestins?
How Do Progestins Work in Cancer Treatment?
Which Cancers Are Treated with Progestins?
What Are the Benefits of Progestins in Cancer Therapy?
What Are the Side Effects of Progestins?
Are There Any Risks Associated with Long-Term Use of Progestins?
How Are Progestins Administered?
What Is the Future of Progestins in Cancer Therapy?
How Does Technology Facilitate Real-Time Access?
What Challenges Do Spiritual Care Departments Face?
What role do patient advocacy groups play in GA4GH?
What is Resistance to BCR-ABL Inhibitors?
How Can Institutions Join AACR Project GENIE?
What are the Consequences of Untreated Sleep Disorders in Cancer Patients?
Can I Deduct Costs for Home Care?
Are There Any Limitations to CIRS?
What is Proliferation?
What Are Common Risk Factors?
What Are the Challenges in Using Data Science for Cancer Research?
What is the Impact on Quality of Life?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe